Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Trial of Curcumin in Advanced Pancreatic Cancer

This study has been completed.
Sabinsa Corporation
Information provided by (Responsible Party):
M.D. Anderson Cancer Center Identifier:
First received: October 18, 2004
Last updated: April 29, 2014
Last verified: April 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2014
  Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)